A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss

International Journal of Andrology

Volumn 24, Issue 4, 2001, Pages 232-240

  Batterham, Marijka Jane ^a,b   Garsia, Roger ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Dietary counselling; HIV; Megestrol acetate; Nandrolone decanoate; Weight loss

Indexed keywords

ANTIRETROVIRUS AGENT; MEGESTROL ACETATE; NANDROLONE DECANOATE;

ADULT; APPETITE; ARTICLE; BODY COMPOSITION; BODY FAT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DIETARY INTAKE; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT PLANNING; WEIGHT REDUCTION;

ADULT; ANABOLIC AGENTS; APPETITE; COUNSELING; EATING; HIV WASTING SYNDROME; HUMANS; MALE; MEGESTROL ACETATE; MIDDLE AGED; NANDROLONE; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 0034920341     PISSN: 01056263     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2605.2001.00291.x     Document Type: Article

References (50)

1. Calculation energy requirements for people with HIV/AIDS
2. Dietary intake, serum lipids, insulin resistance and body composition in the era of highly active antiretroviral
3. HIV risk behaviours among gay men who use anabolic steroids
4. Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer
5. Monitoring dietary change in a low-fat diet intervention study: Advantages of using 24-hour dietary recalls vs food records
6. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society - USA panel
7. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
8. Prognostic factors correlated with survival in AIDS patients
9. Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS
10. Dietary intake and counseling, weight maintenance, and the course of HIV infection
11. Treatments for wasting in patients with the acquired immunodeficiency syndrome
12. Human energy requirements: Overestimation by widely used prediction equation
13. Changes in body habitus and serum lipid abnormalities in HIV-positive women of highly active antiretroviral therapy (HAART)
14. Effects of megestrol acetate therapy upon body composition and serum testosterone in AIDS
15. Effects of megestrol acetate and testosterone on body composition in castrated male sprague-dawley rats
16. Atherogenic effects of anabolic steroids on serum lipid levels. A literature review
17. Lack of demonstrated effect of nandrolone on serum lipids
18. Nandrolone decanoate; use in HIV-associated lipodystrophy syndrome: A pilot study
19. Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection
20. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial
21. Hit HIV-1 hard, but only when necessary
22. Total energy expenditure in juman immunodeficiency virus-infected men and healthy controls
23. Diabetes mellitus induced by megestrol acetate in a patient with AIDS and cachexia
24. Anabolic effects of nandrolone decanoate in patients receiving dialysis
25. Induction of adrenal suppression by megestrol acetate
26. Anabolic steroids in deficiency states
27. Side effects and contraindications of anabolic steroids
28. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS
29. Induction of adrenal suppression by megestrol acetate in patients with AIDS
30. 'Buffalo hump' in men with HIV-1 infection
31. Induction of adrenal suppression on megestrol acetate
32. Biological indexes considered in the derivation of the bioelectrical impedance analysis
33. Unusual distributions of body fat in AIDS patients: A review of adverse events reported to the food and drug administration
34. Megestrol for AIDS-related anorexia
35. Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients
36. Visceral abdominal-fat accumulation associated with use of indinavir
37. Megestrol acetate vs tamoxifen in advanced breast cancer in postmenopausal patients
38. Viral load and resting energy expenditure in men with HIV infection
39. Hyperlipidaemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection
40. Nutrition in human immunodeficiency virus (HIV) disease
41. Megestrol acetate in patients with AIDS and cachexia
42. Hyperglycemia induced by megestrol acetate
43. A syndrome of body fat redistribution in HIV-1-infected patients: Relationships to cortisol and catecholamines
44. Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus
45. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial
46. Induction of adrenal suppression by megestrol acetate
47. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss
48. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
49. When and where to start: Guidelines for the initiation of antiretroviral therapy
50. Megestrol acetate in patients with AIDS-related cachexia